Ocular Inflammation
📧 Sign up to get email alerts when something new happens for Ocular Inflammation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-11Clinical Trial Update: A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery [Phase 3]
Phase 3 study evaluating the efficacy and safety of OCS-01 eyedrops versus vehicle for ocular inflammation and pain after cataract surgery h…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: Bromfenac Versus Dexamethasone After Cataract Surgery [Phase 4]
The completed Phase 4 study compares bromfenac with dexamethasone for inflammation after cataract surgery.
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery [Phase 2]
Phase 2 trial of VVN461 Ophthalmic Solution for post-operative ocular inflammation after cataract surgery has completed and results have bee…
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy of an Oral Supplement in Supporting Vision and Eye Health [NA]
This document reports the completion of a clinical trial evaluating an oral supplement intended to support vision and eye health.
-
CLINICAL_TRIALS trial_result · 2023-07-05Clinical Trial Update: Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery [Phase 3]
Phase 3 trial update on APP13007 for ocular inflammation and pain after cataract surgery; results posted in 2023.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-04-19Clinical Trial Update: RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery [Phase 2]
Phase 2 trial of RTA 408 ophthalmic suspension for ocular inflammation and pain following ocular surgery has completed, with results posted …
-
CLINICAL_TRIALS trial_result · 2022-03-07Clinical Trial Update: Efficacy and Safety of Saturno IIB Association on the Control of Ocular Inflammation Post-phacoemulsification [Phase 2]
A Phase 2 trial update reports efficacy and safety of Saturno IIB association for controlling ocular inflammation after cataract surgery.
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation [Phase 3]
Phase 3 trial assessing KPI-121 for safety and efficacy in postsurgical ocular inflammation/infection completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-09-03Clinical Trial Update: Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery [Phase 3]
Phase 3 trial update for mapracorat ophthalmic suspension 3% aimed at treating ocular inflammation and pain after cataract surgery; study co…
-
CLINICAL_TRIALS trial_result · 2020-09-03Clinical Trial Update: Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery [Phase 3]
Phase 3 trial results for mapracorat ophthalmic suspension 3% in treating ocular inflammation and pain after cataract surgery have been comp…
-
CLINICAL_TRIALS trial_result · 2020-04-14Clinical Trial Update: LE Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery [Phase 3]
Phase 3 trial update for LE Gel in treating ocular inflammation and pain after cataract surgery has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-07Clinical Trial Update: KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children [Phase 3]
Phase 3 trial comparing KPI-121 1% to prednisolone for ocular inflammation after pediatric cataract surgery was terminated; results posted i…
-
CLINICAL_TRIALS trial_result · 2019-11-20Clinical Trial Update: Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo. [Phase 4]
Phase 4 trial evaluating PRO-155 for inflammation of the conjunctival surface in Grade I-III pterygium versus placebo; results posted after …
-
CLINICAL_TRIALS trial_result · 2019-02-05Clinical Trial Update: Efficacy and Safety of RX-10045 Ophthalmic Solution for Ocular Inflammation and Pain in Cataract Surgery [Phase 2]
Phase 2 trial evaluating efficacy and safety of RX-10045 ophthalmic solution for ocular inflammation and pain after cataract surgery; result…
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery [NA]
A completed clinical trial comparing bromfenac 0.07% once daily to nepafenac 0.3% once daily for ocular inflammation after cataract surgery,…
-
CLINICAL_TRIALS trial_result · 2018-10-22Clinical Trial Update: Clinical Outcomes and Evaluation of Lotemax 0.5% in Treatment of Ocular Inflammation Associated With Cataract Surgery
Clinical trial update reporting outcomes of Lotemax 0.5% for ocular inflammation after cataract surgery in pseudophakia patients; results po…
-
CLINICAL_TRIALS trial_result · 2018-07-24Clinical Trial Update: PGE2 Levels in Patient Treated With NSAIDs [Phase 3]
Phase 3 clinical trial update on PGE2 levels in patients treated with NSAIDs for ocular inflammation. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Phase II Study Evaluating Safety/Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery [Phase 2]
Phase II study evaluating safety and efficacy of OTX-DP for ocular inflammation and pain after cataract surgery has completed with results p…
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation [Phase 3]
Phase 3 clinical trial results evaluating XG-102 for reducing post-cataract surgery intraocular inflammation have been completed, with repor…
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation and Pain [Phase 3]
Phase 3 trial of XG-102 for reducing post-cataract surgery intraocular inflammation and pain has completed, evaluating efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects [Phase 3]
Phase 3 trial comparing ISV-303 to DuraSite vehicle in ocular inflammation after cataract surgery completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Study to Compare Differing Dosing Regimens of ISV-303 (Bromfenac in DuraSite) to Xibrom and Vehicle in Post Cataract Surgery Volunteers [Phase 1, Phase 2]
A phase 1/2 trial comparing dosing regimens of ISV-303 (bromfenac in DuraSite) to Xibrom and vehicle in ocular inflammation following catara…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects [Phase 3]
Phase 3 trial comparing ISV-303 to Durasite vehicle in cataract surgery patients with ocular inflammation has completed with results posted …
-
CLINICAL_TRIALS trial_result · 2013-09-18Clinical Trial Update: Efficacy and Safety Study of IBI-10090 in Cataract Surgery Patients [Phase 2]
Phase 2 trial of IBI-10090 in ocular inflammation associated with cataract surgery was terminated; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery [Phase 3]
Phase 3 trial update evaluating the safety and efficacy of bromfenac ophthalmic solution for reducing ocular inflammation and pain after cat…